Anticholinergic agents refer to medication drugs that block the action of acetylcholine , a neurotransmitter with an effect opposite to that of dopamine . By blocking the action of acetylcholine, these drugs increase the ability of dopamine to control movement. Examples of anticholinergic drugs used in the treatment of Parkinson disease include trihexyphenidyl (Artane®), benztropine (Cogentin®), and ethopropazine (Parsidol®).

Related Articles

Anticholinesterase at psychology-glossary.com■■■■■
Anticholinesterase refers to an agent that inhibits action of acetylcholinesterase (AChE). AChE is an . . . Read More
Anticholinergic hallucinogens at psychology-glossary.com■■■■■
Anticholinergic hallucinogens refer to a class of drugs including Atropine and Scopolamine; - - Anticholinergic . . . Read More
L-dopa at psychology-glossary.com■■■■
L-dopa is chemical precursor of Dopamine and other catecholamines ; chemical precursor of Dopamine used . . . Read More
Dopamine at psychology-glossary.com■■■■
Dopamine refers to neurotransmitter whose generalized function is to activate other neurotransmitters . . . Read More
Amantadine at psychology-glossary.com■■■■
Amantadine is a synthetic antiviral agent that also has strong antiparkinsonian properties. It is sold . . . Read More
Apomorphine at psychology-glossary.com■■■■
Apomorphine is a type of drug that is being studied to treat severe Parkinson’s disease. It is made . . . Read More
Agonist at psychology-glossary.com■■■■
Agonist refers to a drug that effectively mimics the action  of a natural chemical messenger within . . . Read More
Aspirin at psychology-glossary.com■■■■
Aspirin is not typically discussed in the context of psychology, as it is primarily known as a medication . . . Read More
Methylphenidate at psychology-glossary.com■■■■
Methylphenidate refers to the Stimulant medication most commonly used in treating children with attention . . . Read More
Stimulant Medications at psychology-glossary.com■■■■
- Stimulant Medications : Stimulant Medications refer to drugs that alter the activity in the frontostriatal . . . Read More